Stock Earnings

Question 1

Clinuvel Pharmaceuticals Ltd의 주요 재무제표는 무엇인가요?

Accepted Answer

최신 재무제표(Form-10K)에 따르면, Clinuvel Pharmaceuticals Ltd의 총 자산은 $271이며, 순profit입니다.

Question 2

CLVLF의 주요 재무 비율은 무엇인가요?

Accepted Answer

Clinuvel Pharmaceuticals Ltd의 유동비율은 9.03이고, 순이익률은 37.89, 주당 매출은 $1.88입니다.

Question 3

Clinuvel Pharmaceuticals Ltd의 매출은 부문 또는 지역별로 어떻게 나뉘나요?

Accepted Answer

Clinuvel Pharmaceuticals Ltd largest revenue segment is Biopharmaceutical, at a revenue of 88,178,308 in the most earnings release.For geography, Europe & United States is the primary market for Clinuvel Pharmaceuticals Ltd, at a revenue of 81,483,000.

Question 4

Clinuvel Pharmaceuticals Ltd은 수익성이 있나요?

Accepted Answer

yes, 최신 재무제표에 따르면 Clinuvel Pharmaceuticals Ltd의 순profit은 $36입니다.

Question 5

Clinuvel Pharmaceuticals Ltd에 부채가 있나요?

Accepted Answer

yes, Clinuvel Pharmaceuticals Ltd의 부채는 30입니다.

Question 6

Clinuvel Pharmaceuticals Ltd의 발행 주식은 몇 주인가요?

Accepted Answer

Clinuvel Pharmaceuticals Ltd의 총 발행 주식은 50.12주입니다.

Breakdown	TTM	06/30/2025	06/30/2024	06/30/2023	06/30/2022	06/30/2021
Revenue	95	95	95	82	66	48
Revenue Growth (YoY)	0%	0%	16%	24%	38%	45%
Cost of Revenue	1	1	-1	-7	1	-1
Gross Profit	93	93	96	89	64	50
Selling, General & Admin	38	38	37	39	27	19
Research & Development	7	7	2	1	1	0
Operating Expenses	47	47	41	41	29	20
Other Non Operating Income (Expenses)	0	0	--	--	--	0
Pretax Income	51	51	50	45	34	25
Income Tax Expense	15	15	15	14	13	0
Net Income	36	36	35	30	20	24
Net Income Growth	3%	3%	17%	50%	-17%	60%
Shares Outstanding (Diluted)	50.49	50.37	51.02	51.81	51.77	51.13
Shares Change (YoY)	0%	-1%	-2%	0%	1%	1%
EPS (Diluted)	0.71	0.71	0.69	0.59	0.4	0.48
EPS Growth	2%	3%	18%	46%	-17%	62%
Free Cash Flow	40	40	31	35	39	18
Free Cash Flow Per Share	0.79	0.79	0.6	0.67	0.75	0.35
Gross Margin	97.89%	97.89%	101.05%	108.53%	96.96%	104.16%
Operating Margin	47.36%	47.36%	57.89%	58.53%	53.03%	60.41%
Profit Margin	37.89%	37.89%	36.84%	36.58%	30.3%	50%
Free Cash Flow Margin	42.1%	42.1%	32.63%	42.68%	59.09%	37.5%
EBITDA	46	46	56	48	35	29
EBITDA Margin	48.42%	48.42%	58.94%	58.53%	53.03%	60.41%
D&A For EBITDA	1	1	1	0	0	0
EBIT	45	45	55	48	35	29
EBIT Margin	47.36%	47.36%	57.89%	58.53%	53.03%	60.41%
Effective Tax Rate	29.41%	29.41%	30%	31.11%	38.23%	0%

Clinuvel Pharmaceuticals Ltd (CLVLF) Price

CLVLF Stock Price Chart

CLVLF Income

Follow-Up Questions